Clinical Nutrition – The New Tradition is Good Nutrition
Clinical nutrition products are aimed at maintaining a nutritional balance in patients, by providing sufficient amounts of nutrients, such as vitamins, proteins, and minerals. The clinical nutrition products are specially formulated to nourish and improve the quality of life for people of all ages, which is in turn favoring the growth of clinical nutrition market. Oral administration of clinical nutrition products is not viable in patients that have severe infection or burns and are recovering from major surgery or acute trauma. Nutritional need in such patients can be met by specialized nutritional feeding known as enteral or parenteral feeding. The enteral nutrition is a segment of clinical nutrition, which includes liquid formula diets and it is administered by feeding tubes into the gastro intestinal tract. Whereas, parenteral feeding is the clinical nutrition administered by the intravascular route.
The market for clinical nutrition includes a number of companies, which are taking interest in this sector with the introduction of novel products. Before Brands, Inc., a science-based consumer products company, launched SpoonfulOne Daily Food Mix-In, which is a dietary supplement designed for children not having a food allergy. SpponfulOne, helps the body to get know and stay accustomed to the foods responsible for 90% of food allergies. A first-of its kind product is expected to drive interest of medical community in recommending this product to their patients.
Furthermore, nutrition and nutritional care are gaining a wide clinical and scientific interest, which is expected to favor the clinical nutrition market growth. The increased knowledge of metabolic disorders and nutritional assessment in the chronic and acute disease is also expected to boost the growth of clinical nutrition market. Premature births, malnutrition, and increasing geriatric population are demanding for most of the clinical nutrition, which is expected to fuel the global clinical nutrition market. Loss of mass, strength, and function favors the growth of global clinical nutrition market. According to the National Institute on Aging, around 524 million people were recorded to be 65 years of age and above, accounting for around 8% of the world's population in 2010, which is expected to triple in number to 1.5 billion, representing around 16% of the world's population by 2050.
Few growth restraining factors include stringent regulatory scenario and tolerability issues for identified clinical nutrition product. For instance, Cow’s milk protein is intolerant or is allergic leading to common food allergic disease of infancy, which is hampering the growth of clinical nutrition market. The clinical nutrition products carrying health claims are considered as pharmaceutical product and therefore need to undergo the clinical trial process. Besides, lack of awareness regarding the clinical nutrition is expected to hamper growth of the market.
Global Clinical Nutrition Market Share, by Region, 2016
Source: Coherent Market Insights 2017
Increasing Incidence and Diagnosis of Chronic Diseases are Expected to Favor the Growth of Clinical Nutrition Market.
The global clinical nutrition market accounted for US$ 42.2 billion in 2016 and is expected to witness a robust CAGR of 6.3% over the forecast period (2017 - 2025).
Clinical nutrition market is directly related to the growth of disease such as cardiovascular diseases, cancer, dementia, and diabetes. Asia Pacific is the dominant region in the global clinical nutrition market owing to high prevalence of chronic diseases and large pool of patients in this region. The most prevalent chronic diseases in Asia Pacific include cardiovascular diseases (CVD), diabetes, cancer, and chronic respiratory diseases. However, China made mandatory for manufacturers of clinical nutrition products to re-register the baby formulas with the government, this hampered infant clinical nutrition manufacturers’ growth in China in 2016. Furthermore, Centre for Food Safety (CFS),in 2017, observed that Similac Stage 2 had 66% less than the data printed on its nutrition label. Similac Stage 2 should contain 3.8milligrams of niacin per 100g as was declared, however, its actual content was 1.3 milligrams of niacin per 100g, and due to this the baby milk powder was banned from sale in Hong Kong, which in turn hampered the clinical nutrition market in Asia Pacific region.
Malnutrition is an important factor driving the need for clinical nutrition
Malnutrition is treated by the clinical nutrition as these products provide accurate amount of the nutrients required by the body. According to the World Health Organization (WHO), undernutrition is estimated to be associated with 2.7 million (45%) child deaths annually of all child deaths, creating a huge demand for clinical nutrition products. Many manufacturers are promoting the need of clinical nutrition for the infants and children. For instance, Nestlé Ghana in collaboration with the Ghana Nutrition Society held a nutrition workshop in October 2017, to address micronutrient deficiencies in Ghana, which in turn is expected to favor the growth of clinical nutrition market in the Africa region.
Abbott Nutrition has a huge range of nutritional support product across different segments, which include adults, infant and new mother, therapeutic, child, and sports to cater different age groups. Some other major players operating in the clinical nutrition market include Nestle, Fresenius Kabi, Danone, Baxter Healthcare, and B Braun Melsungen AG.